ATM and the Catalytic Subunit of DNA-Dependent Protein Kinase Activate NF-κB through a Common MEK/Extracellular Signal-Regulated Kinase/p90 rsk Signaling Pathway in Response to Distinct Forms of DNA Damage

Molecular and Cellular Biology

Volumn 24, Issue 5, 2004, Pages 1823-1835

  Panta, Ganesh R ^a   Kaur, Swayamjot ^a   Cavin, Lakita G ^a   Cortés, Maria L ^b   Mercurio, Frank ^c   Lothstein, Leonard ^a   Sweatman, Trevor W ^a   Israel, Mervyn ^a   Arsura, Marcello ^a,d  

^a UNIVERSITY OF TENNESSEE CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c CELGENE CORPORATION   (United States)

^d UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ATM PROTEIN; DNA; DNA DEPENDENT PROTEIN KINASE; DOXORUBICIN; DOXORUBICIN DERIVATIVE; I KAPPA B KINASE; I KAPPA B KINASE 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; N BENZYLDOXORUBICIN; PHOSPHATIDYLINOSITOL KINASE; PROTEIN; PROTEIN P53; PROTEIN P90; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DNA DAMAGE; DRUG RESISTANCE; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL CYCLE PROTEINS; CELL SURVIVAL; DNA DAMAGE; DNA-ACTIVATED PROTEIN KINASE; DNA-BINDING PROTEINS; DOXORUBICIN; ENZYME ACTIVATION; ENZYME INHIBITORS; FIBROBLASTS; HUMANS; I-KAPPA B KINASE; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; NF-KAPPA B; NIH 3T3 CELLS; NUCLEAR PROTEINS; PROTEIN SUBUNITS; PROTEIN-SERINE-THREONINE KINASES; RIBOSOMAL PROTEIN S6 KINASES, 90-KDA; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

ANIMALIA; ATAXIA; ATAXIA TELANGIECTASIA;

EID: 1342304040     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.24.5.1823-1835.2004     Document Type: Article

References (55)

1. Arsura, M., F. Mercurio, A. L. Oliver, S. S. Thorgeirsson, and G. E. Sonenshein. 2000. Role of the IκB kinase complex in oncogenic Ras- and Raf-mediated transformation of rat liver epithelial cells. Mol. Cell. Biol. 20:5381-5391.
2. Arsura, M., G. R. Panta, J. D. Bilyeu, L. G. Cavin, M. A. Sovak, A. A. Oliver, V. Factor, R. Heuchel, F. Mercurio, S. S. Thorgeirsson, and G. E. Sonenshein. 2003. Transient activation of NF-κB through a TAK1/IKK kinase pathway by TGF-β1 inhibits AP-1/SMAD signaling and apoptosis: implications in liver tumor formation. Oncogene 22:412-425.
3. Arsura, M., M. Wu, and G. E. Sonenshein. 1996. TGF β1 inhibits NF-κB/Rel activity inducing apoptosis of B cells: transcriptional activation of IκBα. Immunity 5:31-40.
4. Bakkenist, C. J., and M. B. Kastan. 2003. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506.
5. Beg, A. A., W. C. Sha, R. T. Bronson, S. Ghosh, and D. Baltimore. 1995. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376:167-170.
6. Bottero, V., V. Busuttil, A. Loubat, N. Magne, J. L. Fischel, G. Milano, and J. F. Peyron. 2001. Activation of nuclear factor κB through the IKK complex by the topoisomerase poisons SN38 and doxorubicin: a brake to apoptosis in HeLa human carcinoma cells. Cancer Res. 61:7785-7791.
7. Brown, K., S. Gerstberger, L. Carlson, G. Franzoso, and U. Siebenlist. 1995. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485-1488.
8. Chan, D. W., B. P. Chen, S. Prithivirajsingh, A. Kurimasa, M. D. Story, J. Qin, and D. J. Chen. 2002. Autophosphorylation of the DNA-dependent protein kinase catalytic subunit is required for rejoining of DNA double-strand breaks. Genes Dev. 16:2333-2338.
9. Cortes, M. L., C. J. Bakkenist, M. V. Di Maria, M. B. Kastan, and X. O. Breakefield. 2003. HSV-1 amplicon vector-mediated expression of ATM cDNA and correction of the ataxia-telangiectasia cellular phenotype. Gene Ther. 10:1321-1327.
10. Das, K. C., and C. W. White. 1997. Activation of NF-κB by antineoplastic agents. Role of protein kinase C. J. Biol. Chem. 272:14914-14920.
11. Duyao, M. P., A. J. Buckler, and G. E. Sonenshein. 1990. Interaction of an NF-κB-like factor with a site upstream of the c-myc promoter. Proc. Natl. Acad. Sci. USA 87:4727-4731.
12. Frantz, B., E. C. Nordby, G. Bren, N. Steffan, C. V. Paya, R. L. Kincaid, M. J. Tocci, S. J. O'Keefe, and E. A. O'Neill. 1994. Calcineurin acts in synergy with PMA to inactivate IκB/MAD3, an inhibitor of NF-κB. EMBO J. 13:861-870.
13. Ghoda, L., X. Lin, and W. C. Greene. 1997. The 90-kDa ribosomal S6 kinase (pp90rsk) phosphorylates the N-terminal regulatory domain of IκBα and stimulates its degradation in vitro. J. Biol. Chem. 272:21281-21288.
14. Harvey, D. M., and A. J. Levine. 1991. p53 alteration is a common event in the spontaneous immortalization of primary BALB/c murine embryo fibroblasts. Genes Dev. 5:2375-2385.
15. Huang, T. T., S. M. Wuerzberger-Davis, B. J. Seufzer, S. D. Shumway, T. Kurama, D. A. Boothman, and S. Miyamoto. 2000. NF-κB activation by camptothecin. A linkage between nuclear DNA damage and cytoplasmic signaling events. J. Biol. Chem. 275:9501-9509.
16. Hur, G. M., J. Lewis, Q. Yang, Y. Lin, H. Nakano, S. Nedospasov, and Z. G. Liu. 2003. The death domain kinase RIP has an essential role in DNA damage-induced NF-κB activation. Genes Dev. 17:873-882.
17. Kastan, M. B., and D. S. Lim. 2000. The many substrates and functions of ATM. Nat. Rev. Mol. Cell Biol. 1:179-186.
18. Kharbanda, S., P. Pandey, T. Yamauchi, S. Kumar, M. Kaneki, V. Kumar, A. Bharti, Z. M. Yuan, L. Ghanem, A. Rana, R. Weichselbaum, G. Johnson, and D. Kufe. 2000. Activation of MEK kinase 1 by the c-Abl protein tyrosine kinase in response to DNA damage. Mol. Cell. Biol. 20:4979-4989.
19. Kharbanda, S., A. Saleem, T. Shafman, Y. Emoto, R. Weichselbaum, and D. Kufe. 1994. Activation of the pp90rsk and mitogen-activated serine/threonine protein kinases by ionizing radiation. Proc. Natl. Acad. Sci. USA 91:5416-5420.
20. Kharbanda, S., Z. M. Yuan, R. Weichselbaum, and D. Kufe. 1998. Determination of cell fate by c-Abl activation in the response to DNA damage. Oncogene 17:3309-3318.
21. Kim, S. T., D. S. Lim, C. E. Canman, and M. B. Kastan. 1999. Substrate specificities and identification of putative substrates of ATM kinase family members. J. Biol. Chem. 274:37538-37543.
22. Kurimasa, A., S. Kumano, N. V. Boubnov, M. D. Story, C. S. Tung, S. R. Peterson, and D. J. Chen. 1999. Requirement for the kinase activity of human DNA-dependent protein kinase catalytic subunit in DNA strand break rejoining. Mol. Cell. Biol. 19:3877-3884.
23. Lee, S. A., A. Dritschilo, and M. Jung. 1998. Impaired ionizing radiation-induced activation of a nuclear signal essential for phosphorylation of c-Jun by dually phosphorylated c-Jun amino-terminal kinases in ataxia telangiectasia fibroblasts. J. Biol. Chem. 273:32889-32894.
24. Lee, S. J., A. Dimtchev, M. F. Lavin, A. Dritschilo, and M. Jung. 1998. A novel ionizing radiation-induced signaling pathway that activates the transcription factor NF-κB. Oncogene 17:1821-1826.
25. Li, J. D., W. Feng, M. Gallup, J. H. Kim, J. Gum, Y. Kim, and C. Basbaum. 1998. Activation of NF-κB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells. Proc. Natl. Acad. Sci. USA 95:5718-5723.
26. Li, N., S. Banin, H. Ouyang, G. C. Li, G. Courtois, Y. Shiloh, M. Karin, and G. Rotman. 2001. ATM is required for IκB kinase (IKKk) activation in response to DNA double strand breaks. J. Biol. Chem. 276:8898-8903.
27. Lin, R., P. Beauparlant, C. Makris, S. Meloche, and J. Hiscott. 1996. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol. 16:1401-1409.
28. Lothstein, L., D. P. Suttle, J. F. Roaten, Y. Koseki, M. Israel, and T. W. Sweatman. 2000. Catalytic inhibition of DNA topoisomerase II by N-benzyladriamycin (AD 288). Biochem. Pharmacol. 60:1621-1628.
29. Lothstein, L., H. M. Wright, T. W. Sweatman, and M. Israel. 1992. N-benzyladriamycin-14-valerate and drug resistance: correlation of anthracycline structural modification with intracellular accumulation and distribution in multidrug resistant cells. Oncol. Res. 4:341-347.
30. Lowe, S. W., H. E. Ruley, T. Jacks, and D. E. Housman. 1993. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 74:957-967.
31. Mayo, M. W., and A. S. Baldwin. 2000. The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta 1470:M55-M62.
32. Mercurio, F., and A. M. Manning. 1999. Multiple signals converging on NF-κB. Curr. Opin. Cell Biol. 11:226-232.
33. Mercurio, F., B. W. Murray, A. Shevchenko, B. L. Bennett, D. B. Young, J. W. Li, G. Pascual, A. Motiwala, H. Zhu, M. Mann, and A. M. Manning. 1999. IκB kinase (IKK)-associated protein 1, a common component of the heterogeneous IKK complex. Mol. Cell. Biol. 19:1526-1538.
34. Mercurio, F., H. Zhu, B. W. Murray, A. Shevchenko, B. L. Bennett, J. Li, D. B. Young, M. Barbosa, M. Mann, A. Manning, and A. Rao. 1997. IKK-1 and IKK-2: cytokine-activated IκB kinases essential for NF-κB activation. Science 278:860-866.
35. Murnane, J. P., L. F. Fuller, and R. B. Painter. 1985. Establishment and characterization of a permanent pSV ori-transformed ataxia-telangiectasia cell line. Exp. Cell Res. 158:119-126.
36. Peterson, S. R., A. Kurimasa, M. Oshimura, W. S. Dynan, E. M. Bradbury, and D. J. Chen. 1995. Loss of the catalytic subunit of the DNA-dependent protein kinase in DNA double-strand-break-repair mutant mammalian cells. Proc. Natl. Acad. Sci. USA 92:3171-3174.
37. Piret, B., and J. Piette. 1996. Topoisomerase poisons activate the transcription factor NF-κB in ACH-2 and CEM cells. Nucleic Acids Res. 24:4242-4248.
38. Piret, B., S. Schoonbroodt, and J. Piette. 1999. The ATM protein is required for sustained activation of NF-κB following DNA damage. Oncogene 18:2261-2271.
39. Pommier, Y., F. Leteurtre, M. R. Fesen, A. Fujimori, R. Bertrand, E. Solary, G. Kohlhagen, and K. W. Kohn. 1994. Cellular determinants of sensitivity and resistance to DNA topoisomerase inhibitors. Cancer Investig. 12:530-542.
40. Reed, J. C., T. Miyashita, S. Takayama, H. G. Wang, T. Sato, S. Krajewski, C. Aime-Sempe, S. Bodrug, S. Kitada, and M. Hanada. 1996. BCL-2 family proteins: regulators of cell death involved in the pathogenesis of cancer and resistance to therapy. J. Cell. Biochem. 60:23-32.
41. Ryan, K. M., M. K. Ernst, N. R. Rice, and K. H. Vousden. 2000. Role of NF-κB in p53-mediated programmed cell death. Nature 404:892-897.
42. Saeki, Y., C. Fraefel, T. Ichikawa, X. O. Breakefield, and E. A. Chiocca. 2001. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome. Mol. Ther. 3:591-601.
43. Sarkaria, J. N., E. C. Busby, R. S. Tibbetts, P. Roos, Y. Taya, L. M. Karnitz, and R. T. Abraham. 1999. Inhibition of ATM and ATR kinase activities by the radiosensitizing agent caffeine. Cancer Res. 59:4375-4382.
44. Sarkaria, J. N., R. S. Tibbetts, E. C. Busby, A. P. Kennedy, D. E. Hill, and R. T. Abraham. 1998. Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. Cancer Res. 58:4375-4382.
45. Schouten, G. J., A. C. Vertegaal, S. T. Whiteside, A. Israel, M. Toebes, J. C. Dorsman, A. J. van der Eb, and A. Zantema. 1997. IκB alpha is a target for the mitogen-activated 90 kDa ribosomal S6 kinase. EMBO J. 16:3133-3144.
46. Shafman, T. D., A. Saleem, J. Kyriakis, R. Weichselbaum, S. Kharbanda, and D. W. Kufe. 1995. Defective induction of stress-activated protein kinase activity in ataxia-telangiectasia cells exposed to ionizing radiation. Cancer Res. 55:3242-3245.
47. Shiloh, Y., and M. B. Kastan. 2001. ATM: genome stability, neuronal development, and cancer cross paths. Adv. Cancer Res. 83:209-254.
48. Tang, D., D. Wu, A. Hirao, J. M. Lahti, L. Liu, B. Mazza, V. J. Kidd, T. W. Mak, and A. J. Ingram. 2002. ERK activation mediates cell cycle arrest and apoptosis after DNA damage independently of p53. J. Biol. Chem. 277:12710-12717.
49. Tergaonkar, V., M. Pando, O. Vafa, G. Wahl, and I. Verma. 2002. p53 stabilization is decreased upon NFκB activation: a role for NFκB in acquisition of resistance to chemotherapy. Cancer Cell 1:493-503.
50. Vertegaal, A. C., H. B. Kuiperij, S. Yamaoka, G. Courtois, A. J. van der Eb, and A. Zantema. 2000. Protein kinase C-alpha is an upstream activator of the IκB kinase complex in the TPA signal transduction pathway to NF-κB in U2OS cells. Cell. Signal. 12:759-768.
51. Wang, C. Y., J. C. Cusack, Jr., R. Liu, and A. S. Baldwin, Jr. 1999. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med. 5:412-417.
52. Wang, C. Y., D. C. Guttridge, M. W. Mayo, and A. S. Baldwin, Jr. 1999. NF-κB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosis. Mol. Cell. Biol. 19:5923-5929.
53. Wang, X., C. H. McGowan, M. Zhao, L. He, J. S. Downey, C. Fearns, Y. Wang, S. Huang, and J. Han. 2000. Involvement of the MKK6-p38γ cascade in gamma-radiation-induced cell cycle arrest. Mol. Cell. Biol. 20:4543-4552.
54. Xie, J., M. Aszterbaum, X. Zhang, J. M. Bonifas, C. Zachary, E. Epstein, and F. McCormick. 2001. A role of PDGFRα in basal cell carcinoma proliferation. Proc. Natl. Acad. Sci. USA 98:9255-9259.
55. Zambetti, G. P., R. S. Quartin, J. Martinez, I. Georgoff, J. Momand, D. Dittmer, C. A. Finlay, and A. J. Levine. 1991. Regulation of transformation and the cell cycle by p53. Cold Spring Harbor Symp. Quant. Biol. 56:219-225.